He points out Lilly isn't planning to file with the FDA until early 2027, so anything sold online now is unapproved. A caution worth reading before buying.
Recap by typeshit. Post by @dradonissaremi on Instagram.
One study cited by @fittrwithsquats put the risk of non-scarring hair loss about 40% higher with GLP-1 use, mostly telogen effluvium. Nail findings are less consistent.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
10:37
PBS NewsHour reports on the growing research into whether GLP-1 medications could help with addiction to alcohol and other drugs.
The clinic points to work by Diogo Pinto da Costa Viana and colleagues on how tirzepatide may interact with progestogen pills taken as part of hormone therapy.
Loading…